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1 |  INTRODUCTION
Aging is one of the inevitably dominant risk associated with 
many diseases.
Several biological factors contribute to this etiology which 
include loss of telomeres, stem cells activity and metabolism, 
escalation of environmental and biological stress, dysfunction-
ing of various micro- and macromolecules, and cell cycle and 
weakening of immune system (Franceschi et al., 2018). In case 
of cellular and molecular damage before elderly age, injury is 
healed to maintain the hemostasis. Nonetheless, with aging, re-
pair mechanism is slowed or completely halted, leading to num-
ber of pathologies (Cortopassi, Gurung, & Pinto-Plata, 2017).
Nearly half of the world's population is infected by 
Helicobacter pylori; however, its prevalence varies geo-
graphically (Melese, Genet, Zeleke, & Andualem, 2019).
Cytotoxin-associated gene A (CagA) and vacuolating cy-
totoxin (VacA) antigens are chiefly responsible for the patho-
genesis of H. pylori infection. Lipopolysaccharides, flagellin, 
and other toxins have strong ability to manipulate host im-
mune response by the activation of chemokine and cytokine 
production pathways, recruitment of immune cells, produc-
tion of autoantibodies, and having a long-term chronic sys-
temic inflammatory response (Chmiela & Gonciarz, 2017).
With age, H. pylori infection is seen to bring about gas-
tric changes such as increase in pepsinogen II and gastrin-17, 
and subsequent decline in pepsinogen I:II ratio, which might 
manifest other pathologies (Morandini et al., 2018; Shan, 
Bai, Han, Yuan, & Sun, 2017). H. pylori-infected patients 
remain asymptomatic in a greater portion of their lives, 
whereas greatest zone of gastric problems is consequently 
associated with H. pylori infection such as peptic ulcers, 
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Helicobacter pylori is one of the most prevalent infection worldwide. It affects in-
dividuals of different age groups. Elderly people tend to resist eradication treatment 
and worsening of infection can lead to several gastric and non-gastric pathologies. 
Aging-associated cellular and molecular alteration can increase the risk of other pa-
thologies such as osteoporosis, Alzheimer's disease, Parkinson's disease, respiratory 
and renal dysfunction, and cancer in geriatric patients, more than other age groups. 
This review article highlights some of the most common old age diseases and the 
role of H. pylori infection as a risk factor to worsen the conditions, presented by the 
molecular evidences of these associations. These studies can help clinicians to un-
derstand the underlying pathogenesis of the disease and identify high-risk patients, 
aiding clearer diagnosis and treatment.
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mucosa-associated lymphoid tissue lymphoma, functional 
dyspepsia, and gastric cancer. Additionally, it is also asso-
ciated with the risk of extragastric diseases (Zendehdel & 
Roham, 2019). In geriatric patients, 70% of the infection is 
seen in the form of gastric diseases, with higher severity and 
hospitalization rate.
Treatment of H. pylori infection is based on triple therapy 
that includes: clarithromycin, metronidazole, and a proton 
pump inhibitor (PPI). Failure to respond to this treatment is 
likely due to the development of resistance against antibiot-
ics, particularly in geriatric population (Moradniani et al., 
2018). Elderly patients, who are already on drugs, also fail to 
respond to this treatment, caused by alteration in the interac-
tion of the drugs such as omeprazole (PPI) with cardiovascu-
lar medicines (Cizginer, Ordulu, & Kadayifci, 2014). Recent 
studies have shown that elderly patients are 2–3 times more 
prone to antibiotic resistance against 100s of strains of H. py-
lori (Boyanova et al., 2017; Shavakhi et al., 2007). In a recent 
study, Kobayashi et al. (2019) demonstrated that super-el-
derly patients (aged > 75 years) are more prone to acquire H. 
pylori-associated gastric and duodenal ulcers; nonetheless, 
the eradication efficacy did not vary in comparison to the 
other age groups.
The main aim of this review is to highlight extragastric 
risk factor associated with H. pylori infection in geriatric pa-
tients (summarized in Figure 1) and the corresponding mech-
anisms that associated H. pylori infection with the diseases.
2 |  MUSCULOSKELETAL 
DISORDERS
Numerous orthopedic diseases are concerned with aging such 
as osteoarthritis, osteopenia, and sarcopenia. Degeneration of 
tissues, ligaments and cartilage, loss of strength, frailty, obe-
sity, infection, and several deficiencies can be the cause of 
these pathologies.
2.1 | Osteoporosis
Reduction in bone mineral density (BMD) and bone quality 
are two main etiologies of osteoporosis. Most of these cases 
are mediated by aging due to loss of equilibrium between 
bone formation and bone loss, mediated by osteoblasts and 
osteoclasts, respectively. The imbalance of osteoprotegerin 
and receptor activator of nuclear factor-κ kappa B ligand 
(OPG/RANKL) pathway plays a significant role in patho-
genesis of the disease (Song, Xie, Peng, Yu, & Peng, 2015).
Studies have shown that H. pylori infection can lead to 
osteoporosis due to age-related decline in BMD and sys-
temic inflammation caused by the infection (Heidari, 2015; 
Pan, Huang, Chuah, Chiang, & Loke, 2018). Nonetheless, 
contradictory reports are also seen in this regard (Abdolahi, 
Aghaei, & Naghdi, 2017; Upala, Sanguankeo, Wijarnpreecha, 
& Jaruvongvanich, 2016). Kim et al. (2014) reported that 
atrophic gastritis can increase the risk of osteoporosis by 
1.89-fold in elderly population.
H. pylori infection, leading to metabolic abnormalities, is 
also associated with the onset of osteoporosis in aged people 
(Lu, Hao, Liu, Li, & Wang, 2018). Furthermore, treatment 
with PPI, such as pantoprazole, can also exacerbate loss of 
bone density and growth, marked with decrease in levels 
of calcium and osteocalcin concentrations (Matuszewska et 
al., 2016). However, early eradication therapy for H. pylori 
infection is likely to reduce the odds of developing osteo-
porosis (Shih et al., 2016). H. pylori can also cause severe 
decline in serum vitamin D levels, hence compromising bone 
health (Mut Surmeli et al., 2018) and leading to metabolic 
syndrome (discussed later) (Chen et al., 2016a; Zendehdel & 
Arefi, 2019).
2.2 | Osteoarthritis (OA)
It is a chronic condition associated with the progressive loss 
of functionality of bones and associated joints. In geriatric 
population, loss of cell function, increased oxidative stress, 
chronic inflammation, and genetic changes can lead to the 
onset of OA (Loeser & Lotz, 2016).
Different mechanisms have been proposed to understand 
the pathology of the disease. Studies have shown that de-
crease in the expression of tissue growth factor-β (TGF-β), 
upregulation of matrix metalloproteinase (MMP), age-related 
alteration in the methylation of DNA, and elevated chronic in-
flammation and related cytokines such as TNF-α, IL-1β, IL-6, 
IL-8 are some of the causes of OA (Chen, Shen, et al., 2017).
Studies have shown that H. pylori-related upper gastroin-
testinal bleeding is common in aged patients with OA (Kim 
et al., 2016). To it, the usage of drugs like nonsteroidal an-
ti-inflammatory drugs (NSAIDs) and PPI in patients with 
OA might worsen this effect (Chan et al., 2010; Rogoveanu, 
Streba, Vere, Petrescu, & Traistaru, 2015).
2.3 | Sarcopenia
Sarcopenia is characterized by the age-related reduced skele-
tal muscle mass and associated activity, as seen in elderly pa-
tients. It leads to physical and systemic disabilities. Exercise 
and hormone-based treatment, such as testosterone, insulin-
like growth factor-1 (Dhillon & Hasni, 2017), and ghrelin, 
have been used to increase the muscle mass. Ghrelin is found 
to play a significant role in muscle mass and boosting of 
physical activity (Tamaki et al., 2017). Baeg et al. (2015) 
demonstrated that elderly women who are H. pylori positive, 
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as compared to the ones who took H. pylori eradication 
treatment, had lower muscle mass. These results were par-
allel with the prevalence of sarcopenia-associated risk fac-
tors obesity, diabetes, increased WBC count and metabolic 
syndrome. The study by Mantero et al. (2018) also predicted 
that eradication of H. pylori normalizes the levels of ghrelin, 
thereby suggesting that it might play a significant role in re-
storing muscle mass.
Furthermore, the vast amount of studies has proven that H. 
pylori infection leads to impairment of systemic immunity. It 
F I G U R E  1  summarizes the links between aging, Helicobacter pylori infection, and extragastric diseases 
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also leads to chronic inflammation by activation of various 
pathways and expression of microRNAs for the production 
of inflammatory cytokines (IL-1β, INF-γ, IL-6, and TNF-
α). Macrophages (M1) and neutrophil-mediated inflamma-
tion is also elevated due to the infection (Cadamuro, Rossi, 
Maniezzo, & Silva, 2014). Once these macrophages and 
neutrophil migrate to the skeletal muscle, they can lead to 
inflammation in the muscles and injury. Progression of the 
age if seen in the form of chronic systemic inflammation, can 
cause loss of muscle mass by the breakdown of muscle pro-
tein (Franceschi et al., 2018).
3 |  CHRONIC OBSTRUCTIVE 
PULMONARY DISEASE (COPD)
Chronic obstructive pulmonary disease is defined by the ob-
struction in the airflow to the lungs to due chronic inflam-
mation due to presence of harmful particles (e.g., cigarette 
smoke). It is widely associated with several other morbidities 
and is highly prevalent in geriatric population (Azargoon, 
Gholami, Farhadi, Chegni, & Zendedel, 2016). Changes in 
the recoiling capacity of the lungs, lead to difficult expiration 
with the aging. Underlying causes such as loss of physical 
activity, history of smoking, and exposure of harmful gases 
adds to pathophysiology of the disease (Cortopassi et al., 
2017).
H. pylori infection is strongly characterized as one of 
the risk factors for the development of COPD in elderly 
patients; CagA and IgG seropositivity are seen in these pa-
tients (Samareh Fekri, Hashemi Bajgani, Rasti, Yazdani, & 
Mollaie, 2014; Wang, Liu, Zhang, & Lei, 2015). Peng et 
al. (2017) and Wang, Guan, et al. (2015) reported that odds 
ratio of H. pylori infection in COPD patients is 2.11. H. 
pylori pathogens and DNA have been seen in the lungs and 
oral cavity of the infected individuals, thereby it is likely 
to initiate inflammatory response in the lungs. Expression 
of receptors like Toll-like receptors 2 and 4 (TLR-2 and 
TLR-4) and advanced glycation end-products (RAGE) in 
the pulmonary epithelium is responsible for the recognition 
of H. pylori. Long-term exposure to these pathogens, leads 
to chronic inflammatory response and oxidative stress-like 
conditions (Zendedel et al., 2015). The presence of other 
harmful particles in the lungs can significantly enhance 
the immune response, initiated by the bacterial invasion 
(GonzÁlez, Araya, & Rojas, 2018).
4 |  RENAL ABNORMALITIES
Similar to other tissues, upon aging, functions of renal tissue 
are largely compromised too. The decrease in glomeruli fil-
tration rate, alterations in the permeability, reabsorption and 
urine concentration, lessening of podocytes, nephrons and 
kidney volume, nephrosclerosis, hypertrophy, and cyst for-
mation are some of the normal renal changes associated with 
healthy aging (Denic, Glassock, & Rule, 2016).
Chronic kidney disease (CKD) and end-stage renal disease 
(ESRD) are the most significant age-related renal diseases, 
reported in elderly patients (Portilla Franco, Tornero Molina, 
& Gil Gregorio, 2016; Poveda et al., 2017). Eradication of H. 
pylori is likely to have a protective effect against CKD (haz-
ard ratio: 0.69) (Wang et al., 2016a).
Studies have shown that in geriatric patients, co-ex-
istence of peptic ulcer and CKD is higher than other age 
groups (Liang et al., 2014) To it, its severity can advance 
to renal transplant stage (Hussein et al., 2016). Similarly, 
infected patients above 75 + years are also more prone to 
develop ESRD, compared to other ages. These patients are 
mostly hypertensive and diabetic, thereby increasing the 
risk of ESRD. Cardiovascular disorders are also common 
in H. pylori-infected individuals; hence this could connect 
the two pathologies. Furthermore, systemic inflammation, 
as a result of H. pylori infection marked by elevated lev-
els of C-reactive protein (CRP), TNF-α, and IL-6, are also 
associated with the loss-of-kidney function. H. pylori can 
lead to several alterations in the renal function that can be 
seen as, proteinuria, microalbuminuria and other meta-
bolic products. It also increases levels of homocysteine and 
asymmetric dimethylarginine, markers of CKD, in serum 
(Lin et al., 2015). H pylori-mediated decrease in pepsino-
gen I/II ratio is characterized by the diabetes-associated 
nephropathy (Senmaru et al., 2013). Eradication therapy of 
H. pylori infection can decrease the risk of CKD (Wang et 
al., 2016a).
5 |  METABOLIC SYNDROME
Metabolic syndrome is a cluster of several disorders compris-
ing abnormality in the lipid profile, insulin resistance, vis-
ceral obesity, hypertension, increased levels of white blood 
cells (Li et al., 2016), and hyperglycemia. These factors can 
lead to several cardiovascular disorders and diabetes mel-
litus. It is a common condition affecting geriatric population 
(Kapil et al., 2018; Kapil et al., 2018), also leading to frailty 
(Lopez-Garcia et al., 2017), sarcopenia (Chang et al., 2015), 
increasing the risk of fracture (Chen, Chen, Hsieh, Kuo, & 
Chien, 2017), osteoporosis (Cui et al., 2016), and affecting 
cognitive and functional abilities in this group of population 
(Viscogliosi, Donfrancesco, Palmieri, & Giampaoli, 2017). 
Yang and Xuan (2016) demonstrated that H. pylori infection 
is associated with the increased risk of metabolic syndrome 
in Chinese population with the odds ratio of 5.427.
Helicobacter pylori infection in geriatrics can increase the 
risk for the development of insulin resistance (Chen et al., 
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2015), hyperglycemia, and increased body mass index (BMI) 
(Yang, Xuan, & practice, 2016; Zhang et al., 2015). Together 
H. pylori infection and vitamin D deficiency can increase the 
risk of developing metabolic syndrome up to twofold (Chen 
et al., 2016a). Additionally, eradication of H. pylori can re-
store the levels of adiponectin, a marker of obesity in meta-
bolic syndrome (Ando et al., 2013).
6 |  CARDIOVASCULAR DISEASES 
(CVD)
Aging in cardiac tissue is seen in the formation of decline in 
contractility of the myocardium, ejection fraction, and eleva-
tion in the arterial stiffness. These phenomena are validated 
in different studies. Vendrov et al. (2015) demonstrated that 
NAPDH-mediated oxidative stress corresponds to aging-
related incidence of CVD. Increased concentration of mito-
chondrial reactive oxygen species leads to aortic stiffness and 
atherosclerosis. In a recent article, cellular senescence with 
the progression of the age is seen to be related with CVD. 
This is due to elevated systemic inflammatory response and 
oxidative stress. Senescence of endothelium is seen to result 
in heart failure with persevered ejection fraction that is also 
commonly seen in geriatric population (Shakeri, Lemmens, 
Gevaert, Meyer, & Segers, 2018). It is seen that H. pylori-
seropositive patients have high levels of low-density lipopro-
teins and eradication of H. pylori infection can lower these 
levels (Nam, Ryu, Park, & Park, 2015. To it, H. pylori-posi-
tive geriatric patients have increased risk of developing ath-
erosclerosis and acute coronary syndrome (Carvalho et al., 
2018; Lai, Yang, Lin, & Kao, 2015). They are also at the risk 
of acquiring myocardial infraction, stroke, and peripheral ar-
tery disease (Rahmani et al., 2017; Vijayvergiya & Vadivelu, 
2015).
Aging and H. pylori infection is associated with changes in 
gastric chemicals and progression of cardiovascular diseases 
(Mladenova, 2019; Shan et al., 2017). H. pylori infection is 
seen to result in hypertension, increased arterial stiffness, 
and lipid profile. Atherosclerosis is one of the outcomes of 
chronic inflammation via different pathways. Patients with 
H. pylori infection are found with increased endothelial dys-
function due to high levels of CRPs, and vascular and intra-
cellular adhesion molecules that mediate inflammation. To it, 
other inflammatory markers like TNF-α, IL-1β, IL-6, IL-8, 
INF-γ (interferon gamma), and several coagulation factors 
are also elevated in such conditions that lead to vasoconstric-
tion, impaired endothelial function, that is also mediated by 
the levels of homocysteine, overproliferation of skeletal mus-
cle cells, and production of matrix metalloproteinase, leading 
to atherosclerosis and acute coronary syndrome, respectively. 
These inflammatory chemicals are upregulated by H. pylori 
infection via cyclooxygenase enzyme-2, toll-like receptors, 
and activation of mitogen activated protein kinase (MAPK), 
c-Jun N-terminal kinase (JNK), and other such pathways 
(Vijayvergiya & Vadivelu, 2015). Furthermore, cross-react-
ing antibodies of H. pylori, such as anti-urease and anti-heat 
shock protein (anti-Hsp) antibodies, can bind to antigens 
of endothelium, skeletal muscle cells, and cardiomyocytes, 
thereby maintaining plaques formation and directing im-
mune-destruction of the tissue (Chmiela & Gonciarz, 2017).
In recent studies, it is found that H. pylori and associated 
morbidities are likely to increase the risk of atherosclerosis 
(Hu et al., 2017; Yu et al., 2019).
6.1 | Diabetes mellitus (DM)
Ample studies have reported evidence-based report regard-
ing the positive association between diabetes mellitus and 
H. pylori infection (Hosseininasab Nodoushan & Nabavi, 
2019), particularly in aged individuals (Dat, Yip, & Hanegbi, 
2016). Besides, diabetes-related complications such as dia-
betic nephropathy (Bajaj et al., 2014) and neuropathy (Wang, 
Fu, & Lv, 2014), diabetic gastroparesis (Huang, 2017), and 
retinopathy (Agrawal et al., 2010) also validate the associa-
tion between diabetes mellitus and H. pylori infection. Li et 
al. (2017) in a meta-analysis reported that H. pylori infection 
is chiefly greater in diabetes mellitus patients than in non- 
diabetes mellitus individuals (odds ratio: 1.69).
H. pylori-positive individuals have higher HOMA-IR (ho-
meostatic model assessment-insulin resistance) levels and 
corresponding oxidative stress (Vijayvergiya & Vadivelu, 
2015). Subsequently, HbA1 (glycated hemoglobin) and 8-hy-
droxydeoxy guanosine (8-OHdG), damage to guanine in 
DNA due to oxidative and nitrosactive stress (Flint, Stintzi, 
& Saraiva, 2016) as a result of infiltration of neutrophil, are 
also elevated parameters in infected diabetic patients (Nasif, 
Mukhtar, Nour Eldein, & Ashgar, 2016).
Likewise, the control of diabetes by the usage of glu-
cophage can also lead to lower risk of developing H. py-
lori infection (Tseng, 2018). Treatment of H. pylori might 
be affected by the imbalance in glucose levels (Nam et al., 
2019). In elderly patients, hyperglycemic conditions with H. 
pylori infection can also lead to colorectal cancer and arterial 
plaques (Hu et al., 2017).
7 |  NEUROLOGICAL DISORDER
Dementia (vascular dementia [VD] and Parkinson's disease 
[PD]) and Alzheimer's disease (AD) are the most common 
types of neurological disorders associated with the progres-
sion of age (Callixte et al., 2015). These are characterized 
by the loss of memory (dementia), difficulty to perform cog-
nitive and physical function, and follow orientation. Both, 
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AD and PD, are characterized by the deposits of misfolded 
protein like β-amyloid and α-synuclein, respectively. These 
neurobiological markers and scans are performed to detect 
the disease.
Pathogenesis of AD as seen from different aspects include 
aging of brain, oxidative stress, impairment of mitochon-
drial function, neuroflammation (involving brain cells and 
other immune cells), and corresponding increased levels of 
serum TNF-α, IL-1β, IL-6, INFγ, and tissue growth factor-β 
(TGF-β). IL-6 is permeable to blood–brain barrier (BBB), 
and IL-1β and TNF-α mediate changes in β-amyloid protein 
(ligand for formyl peptide receptor [FPR]) and alter synapses. 
Similarly, oxidative stress leads to increased levels of oxi-
dized protein and lipid products and cause cell senescence, 
which are also identified in AD. Variations in the input from 
the gut can also impose their effects via gut–brain axis. These 
can include degenerative signals from the bacterial toxins and 
thereby studies have also found association of AD with dif-
ferent infectious agents (Caputi & Giron, 2018; Franceschi et 
al., 2018). H. pylori is found to alter the gut–brain axis such 
that it can lead to neurological disorders like depression, anx-
iety, dementia, schizophrenia, and neurodegenerative pathol-
ogies (Budzyński & Kłopocka, 2014). Animal-based study 
has shown that H. pylori infection upregulates the expression 
of various classes of FPRs and other genes, significant for the 
AD, by Hp (2–20) peptide of the bacteria. These genes have 
neuroprotective (MTRNR2L2, APOE) and anti-inflamma-
tory (ANXA1) roles (Contaldi et al., 2017). Other evidences 
suggest that H. pylori can enter brain via oral–nasal passage 
and H. pylori-infected monocytes, able to bypass the pro-
cess of autophagy, can cross BBB, and lead to inflammation 
(Doulberis et al., 2018). Moreover, H. pylori can also cause 
misfolding of tau protein, one of the misfolded proteins re-
sponsible for AD (Wang, Zeng, et al., 2015).
A systemic review of 260 studies concluded that H. py-
lori is likely to induce risk of dementia. Most of these stud-
ies were conducted on patients with the age of 60-years and 
above (Shindler-Itskovitch, Ravona-Springer, Leibovitz, & 
Muhsen, 2016). This is likely because of the chronic inflam-
mation in both the diseases, cross-linking each other (Xu, 
Wang, Liu, Cui, & Zhao, 2016). Consequently, elevated lev-
els of serum YKL-40 (also known as chitinase-3-like protein 
1 [CHI3L1]) are a significant marker for many inflamma-
tory diseases, including neurodegenerative ones, such as 
Alzheimer's (Muszyński, Groblewska, Kulczyńska-Przybik, 
Kułakowska, & Mroczko, 2017). Xu, Wang, Liu, Cui, Lu, 
et al. (2016) demonstrated that CHI3L1 is upregulated in H. 
pylori-positive individuals, presenting vascular dementia and 
hyperlipidemia in aged individuals.
Bu et al. (2015) in their study showed that onset of 
Alzheimer's disease in elderly patients, as seen by the in-
creased levels of β-amyloid, is associated with exposure to 
infectious microbes, including H. pylori.
H. pylori infection is also associated with the increased 
risk of PD in geriatric individuals (Dardiotis et al., 2018). 
Augustin et al. (2019) reported that PD patients presenting 
H. pylori infection have 12 times increased rate of mortal-
ity. There are several different hypotheses to justify these 
studies. The levels of neurotoxins like cholesterol glucosides 
and methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 
are increased as a result of chronic infection that can dete-
riorate brain functionality. Accumulation of α-synuclein in 
the nerve endings of the gut due to infection correspondingly 
contributes to the pathology of PD (Ito et al., 2013). It can 
also lead to the destruction of neuron by crossing the BBB 
via nasal passage. Additionally, disruption of the motor func-
tion as a result of bacterial invasion can affect the absorp-
tion of levodopa drug (for the treatment of PD), where the 
eradication therapy can alleviate these effects. These motor 
functions are greatly impaired in elderly patients especially 
(Çamcı & Oğuz, 2016). Autoantibodies, primarily generated 
against bacterial antigens can also cross the BBB and trigger 
the degenerative response. Alterations in BBB, as a result of 
changes in gut microbiota, has also been suggested as one of 
the causes of H. pylori infection-mediated PD (McGee, Lu, 
& Disbrow, 2018).
8 |  CANCER
Despite cancerous and aging cells being functionally oppo-
site (hyperproliferation vs. cell senescence), there are several 
other factors that can lead to carcinogenesis in aging cells. 
These include age-associated genetic and epigenetic altera-
tions, abnormal proliferation of damaged stem cells, loss 
of protein homeostasis such as that of heat shock proteins, 
lysosome, decline in autophagy, and nutritional imbalance 
(Aunan, Cho, & Søreide, 2017). Levi, Sochacki, Khoury, 
Patel, and Majumdar (2014) showed that H. pylori infec-
tion cancer stem cells aid progression of neoplasm. This is 
mediated by the upregulation of the Wnt/β-catenin pathway, 
increasing the levels of Nanog, Oct4, and c-myc that is also 
overregulated in carcinogenic conditions (Yong et al., 2016; 
Zhan, Rindtorff, & Boutros, 2017).
Chronic systemic inflammation, due to long-term col-
onization of H. pylori infection, increases the risk of lung 
cancer in geriatric population (Samareh-Fekri et al., 2016). 
Traces of H. pylori has been seen in prostate tumors in el-
derly (Al-Marhoon et al., 2015), which is facilitated by im-
balance between apoptosis and growth of the cells (Verit 
et al., 2015). One of the possible links between the two 
diseases could be the chronic inflammation and activation 
of cell proliferating pathways (already discussed) (Dang & 
Liou, 2018).
The odds ratios of correlation between colorectal cancer/
adenoma and H. pylori infection have been reported from 
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1.15 to 10.6 (Butt & Epplein, 2019). Co-existence of insulin 
resistance, hyperglycemia, and H. pylori is associated with 
the increased risk of colorectal adenoma in aged people (Hu 
et al., 2017; Hu et al., 2017). VacA virulency is associates 
H. pylori with colorectal cancer (Mut Surmeli et al., 2018), 
verified in a recent meta-analysis (Zhao, Wang, & Wang, 
2016), it increases the risk of colorectal neoplasm and adeno-
carcinoma (Kim et al., 2017). In such patients, immune tol-
erance of the bacteria is elevation of tryptophan:kynurenine 
ratio and its metabolite, neoprotein, that mark the inflam-
matory response (Christensen et al., 2018; Engin, Karahalil, 
Karakaya, & Engin, 2015).
H. pylori-seropositive patients are also more prone to ac-
quire laryngeal and hypopharyngeal carcinoma (Guilemany, 
Langdon, Ballesteros, & Blanch, 2014; Zhou, Zhang, Yang, 
Zhou, & Tao, 2016).
9 |  CONCLUSION
Helicobacter pylori infection can be chronic and bypass 
various eradication therapies. In elderly patients, antibiotic 
resistance, chronic inflammation, compromised immunity, 
and retardation of cell activities are the suggested causes 
in this regard. Due to long-term colonization of H. pylori 
infection, its effects are seen systematically, leading to 
several other extragastric disorders. Despite contradictory 
studies reporting no association between H. pylori infec-
tion and some extragastric pathologies (Fotouk-Kiai et al., 
2015; Yu et al., 2014), aging-associated risk factors should 
be considered. Future studies relating aging and H. pylori 
infection with extragastric disease can help to provide 
vivid evidences.
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